Literature DB >> 22753312

ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer.

Louise Hill1, Gareth Browne, Eugene Tulchinsky.   

Abstract

Embryonic differentiation programs of epithelial-mesenchymal and mesenchymal-epithelial transition (EMT and MET) represent a mechanistic basis for epithelial cell plasticity implicated in cancer. Transcription factors of the ZEB protein family (ZEB1 and ZEB2) and several microRNA species (predominantly miR-200 family members) form a double negative feedback loop, which controls EMT and MET programs in both development and tumorigenesis. In this article, we review crosstalk between the ZEB/miR-200 axis and several signal transduction pathways activated at different stages of tumor development. The close association of ZEB proteins with these pathways is indirect evidence for the involvement of a ZEB/miR-200 loop in tumor initiation, progression and spread. Additionally, the configuration of signaling pathways involving ZEB/miR-200 loop suggests that ZEB1 and ZEB2 may have different, possibly even opposing, roles in some forms of human cancer.
Copyright © 2012 UICC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22753312     DOI: 10.1002/ijc.27708

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  113 in total

1.  MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.

Authors:  Lixia Guo; Jingyu Wang; Ping Yang; Qiang Lu; Ting Zhang; Yanan Yang
Journal:  IUBMB Life       Date:  2015-08-27       Impact factor: 3.885

2.  miR-8 modulates cytoskeletal regulators to influence cell survival and epithelial organization in Drosophila wings.

Authors:  Kelsey Bolin; Nicholas Rachmaninoff; Kea Moncada; Katharine Pula; Jennifer Kennell; Laura Buttitta
Journal:  Dev Biol       Date:  2016-02-21       Impact factor: 3.582

Review 3.  Noncoding RNA and colorectal cancer: its epigenetic role.

Authors:  Yoshiaki Kita; Keiichi Yonemori; Yusaku Osako; Kenji Baba; Shinichiro Mori; Kosei Maemura; Shoji Natsugoe
Journal:  J Hum Genet       Date:  2016-06-09       Impact factor: 3.172

4.  ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres.

Authors:  Ulf D Kahlert; Abigail K Suwala; Eric H Raabe; Florian A Siebzehnrubl; Maria J Suarez; Brent A Orr; Eli E Bar; Jaroslaw Maciaczyk; Charles G Eberhart
Journal:  Brain Pathol       Date:  2015-02-08       Impact factor: 6.508

5.  Mesenchymal-Epithelial Transition in Sarcomas Is Controlled by the Combinatorial Expression of MicroRNA 200s and GRHL2.

Authors:  Jason A Somarelli; Samantha Shetler; Mohit K Jolly; Xueyang Wang; Suzanne Bartholf Dewitt; Alexander J Hish; Shivee Gilja; William C Eward; Kathryn E Ware; Herbert Levine; Andrew J Armstrong; Mariano A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  2016-09-12       Impact factor: 4.272

6.  MicroRNA-200b suppresses arsenic-transformed cell migration by targeting protein kinase Cα and Wnt5b-protein kinase Cα positive feedback loop and inhibiting Rac1 activation.

Authors:  Zhishan Wang; Brock Humphries; Hua Xiao; Yiguo Jiang; Chengfeng Yang
Journal:  J Biol Chem       Date:  2014-05-19       Impact factor: 5.157

7.  The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma.

Authors:  E Sánchez-Tilló; L Fanlo; L Siles; S Montes-Moreno; A Moros; G Chiva-Blanch; R Estruch; A Martinez; D Colomer; B Győrffy; G Roué; A Postigo
Journal:  Cell Death Differ       Date:  2013-09-06       Impact factor: 15.828

8.  Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generation.

Authors:  Guiying Wang; Xudong Guo; Wujun Hong; Qidong Liu; Tingyi Wei; Chenqi Lu; Longfei Gao; Dan Ye; Yi Zhou; Jie Chen; Jianmin Wang; Minjuan Wu; Houqi Liu; Jiuhong Kang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-05       Impact factor: 11.205

9.  The EMT regulator ZEB2 is a novel dependency of human and murine acute myeloid leukemia.

Authors:  Hubo Li; Brenton G Mar; Huadi Zhang; Rishi V Puram; Francisca Vazquez; Barbara A Weir; William C Hahn; Benjamin Ebert; David Pellman
Journal:  Blood       Date:  2016-10-18       Impact factor: 22.113

Review 10.  Epithelial-to-mesenchymal transition in tumor progression.

Authors:  Elena Prieto-García; C Vanesa Díaz-García; Inmaculada García-Ruiz; M Teresa Agulló-Ortuño
Journal:  Med Oncol       Date:  2017-05-30       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.